World Emerging Anti-Obesity Prescription Drug Markets
World Emerging Anti-Obesity Prescription Drug Markets
RELEASE DATE
10-Sep-2003
10-Sep-2003
REGION
Global
Global
Research Code: A643-01-00-00-00
SKU: HC00932-GL-MR_04760
$3,950.00
Special Price $2,962.50 save 25 %
In stock
SKU
HC00932-GL-MR_04760
Description
The objective of this Strategic Analysis Service is to equip the C-level and senior exceutives of global healthcare and life sciences companies with cutting edge research, strategic planning, and structured advisory services. The Strategic Analysis of World Emerging Anti-Obesity Prescription Drug Markets provides insight into the present challenges and growth opportunities in the global markets and changing trends that would impact the future potential. The study provides thoughts from the heads of prominent companies of the world with products in development.
Table of Contents
Overview
- Introduction
- Disclaimer
- Certification
- Research Scope and Methodology
- Market Segmentation by Region
- Market Segmentation by Product
- Key Facts 1
- Key Facts 2
Market Dynamics
- Industry Challenges
- CEO Quote
- Market Trends
Demand Analysis
- Prevalence of Obesity - World
- Total Obese Population Forecasts - World
- Obese Population - North America
- Obese Population - Western Europe
- Obese Population Forecasts - U.S. and W. Europe
- Obese Population - Asia Pacific
- Growth Drivers
- CEO Quote
Market Forecasts
- Existing Anti-Obesity Drugs Revenue Forecasts - U.S.
- Total Revenue Forecasts by Geographical Regions - World
- Global Market Size 1999 - 2009
Revenue Analysis
- Market Revenue Analysis
- Revenue Analysis by Geographical Regions
Evolving Markets
- CEO Quote
- Radar Screen
- Customer Priorities and Market Scenario
Growth Strategies
- Achieving Sustained Value Growth
- Market Opportunity Matrix
- Understanding Growth Opportunities 1
- Understanding Growth Opportunities 2
Future Growth Areas
- Growth Rates by Geographical Regions
- Emerging Product's Landscape - I
- Emerging Product's Landscape - II
- Emerging Product's Landscape - III
- Emerging Product's Landscape - IV
- Emerging Product's Landscape - V
Econometrics
- Macro Economic Analysis - I
- Macro Economic Analysis - II
- Macro Economic Analysis - III
- Macro Economic Analysis - IV
- Componenets of Macro Environment
What Future Holds?
- Product Life Cycle Analysis
- Already Known to 2010 and Beyond
- Competition Framework
- Target Markets for Anti-Obesity Treatment
Frost & Sullivan Awards
- Introduction
- Technology Innovation Award
- Product Differentiation Award
- Product Innovation Award
Frost & Sullivan
- Healthcare Team
- Our Capabilities
- Key Advantages
- Our Consulting Clients
- Growth Consulting
- Growth Consulting Process
- Growth Consulting Deliverables
- Growth Partnership Service (GPS)
- Growth Partnership Services Platform
Popular Topics
The objective of this Strategic Analysis Service is to equip the C-level and senior exceutives of global healthcare and life sciences companies with cutting edge research, strategic planning, and structured advisory services. The Strategic Analysis of World Emerging Anti-Obesity Prescription Drug Markets provides insight into the present challenges and growth opportunities in the global markets and changing trends that would impact the future potential. The study provides thoughts from the heads of prominent companies of the world with products in development.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | A643-01-00-00-00 |
Is Prebook | No |